Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Solazyme Inc (NASDAQ:SZYM)

2.34
Delayed Data
As of Jul 31
 -0.60 / -20.41%
Today’s Change
2.00
Today|||52-Week Range
10.20
-9.30%
Year-to-Date

Today’s Trading

Previous close2.94
Today’s open2.52
Day’s range-- - --
Volume1,675,172
Average volume (3 months)705,454
Market cap$187.4M
Dividend yield--
Data as of 07/31/2015

Growth & Valuation

Earnings growth (last year)-18.23%
Earnings growth (this year)+16.17%
Earnings growth (next 5 years)+683.60%
Revenue growth (last year)+51.93%
P/E ratioNM
Price/Sales3.24
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
PSTIPluristem Therapeuti...+0.02+0.84%
FATEFate Therapeutics In...-0.01-0.14%
ASTAsterias Biotherapeu...+0.05+1.03%
ENZYEnzymotec Ltd-0.40-4.70%
Data as of 07/31/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$60.4M
Annual profit (last year)-$162.1M
Net profit margin-268.49%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
Chief Executive Officer &
Director
Jonathan S. Wolfson
Chief Operating &
Financial Officer
Tyler W. Painter
Corporate headquarters
San Francisco, California

Forecasts